Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: AMGN PFE LLY MRK REGN JNJ BMY VRTX GILD BIIB

| Held by: IJH VTI VB VBR VXF XMHQ MDY IBB XBI IJK

Index	-	P/E	17.21	EPS (ttm)	26.39	Insider Own	3.21%	Shs Outstand	42.90M	Perf Week	0.10%
Market Cap	19.55B	Forward P/E	14.99	EPS next Y	30.29	Insider Trans	-30.13%	Shs Float	41.67M	Perf Month	1.13%
Enterprise Value	16.78B	PEG	1.86	EPS next Q	7.07	Inst Own	99.84%	Short Float	4.88%	Perf Quarter	50.58%
Income	1.27B	P/S	6.25	EPS this Y	11.05%	Inst Trans	-2.73%	Short Ratio	2.61	Perf Half Y	47.40%
Sales	3.13B	P/B	2.96	EPS next Y	10.69%	ROA	17.57%	Short Interest	2.03M	Perf YTD	28.67%
Book/sh	153.61	P/C	7.06	EPS next 5Y	9.23%	ROE	20.04%	52W High	479.50 -5.32%	Perf Year	20.49%
Cash/sh	64.28	P/FCF	17.42	EPS past 3/5Y	34.80% -	ROIC	19.30%	52W Low	266.98 70.05%	Perf 3Y	98.78%
Dividend Est.	-	EV/EBITDA	10.50	Sales past 3/5Y	19.52% 14.71%	Gross Margin	88.59%	Volatility	2.96% 3.08%	Perf 5Y	238.23%
Dividend TTM	-	EV/Sales	5.36	EPS Y/Y TTM	17.16%	Oper. Margin	48.46%	ATR (14)	14.18	Perf 10Y	216.27%
Dividend Ex-Date	-	Quick Ratio	6.07	Sales Y/Y TTM	13.50%	Profit Margin	40.65%	RSI (14)	61.78	Recom	1.59
Dividend Gr. 3/5Y	- -	Current Ratio	6.40	EPS Q/Q	12.12%	SMA20	4.35%	Beta	0.86	Target Price	519.75
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	6.76%	SMA50	7.81%	Rel Volume	0.46	Prev Close	447.45
Employees	1305	LT Debt/Eq	0.00	Earnings	Oct 29 BMO	SMA200	34.05%	Avg Volume	779.95K	Price	454.00
IPO	Jun 17, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.14% -1.64%	Trades		Volume	376,507	Change	1.46%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-25	Initiated	Wells Fargo	Underweight	$414
Sep-26-25	Initiated	RBC Capital Mkts	Outperform	$569
Jun-02-25	Initiated	Cantor Fitzgerald	Overweight	$405
Apr-25-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-21-25	Upgrade	BofA Securities	Underperform → Neutral	$314
Jul-11-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$310 → $321
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125

Show Previous Ratings

Nov-05-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
12:35AM	The 5 Most Interesting Analyst Questions From United Therapeutics's Q3 Earnings Call (StockStory)
Nov-04-25 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
07:00AM	United Therapeutics Corporation to Present at Upcoming Investor Conferences (Business Wire)
Nov-03-25 07:00AM	United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease (Business Wire)
03:48PM	Loading…
Oct-30-25 03:48PM	United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
11:40AM	MKKGY vs. UTHR: Which Stock Is the Better Value Option? (Zacks)
01:38AM	UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook (StockStory)
Oct-29-25 04:14PM	United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug (Investor's Business Daily) +9.63%
01:11PM	Why Is United Therapeutics (UTHR) Stock Soaring Today (StockStory)
11:24AM	United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark (Zacks)
09:55AM	The Mixed Results For United Therapeutics' Bread-And-Butter Drug (Investor's Business Daily)
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics (Zacks)
08:51AM	United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short (Investor's Business Daily)
07:40AM	United Therapeutics (UTHR) Beats Q3 Earnings Estimates (Zacks)
06:48AM	Loading…
06:48AM	United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
06:43AM	United Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results (Business Wire)
Oct-27-25 11:17PM	United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-24-25 10:05AM	Merck's Non-Oncology Drugs Q3 Performance: What to Expect (Zacks)
Oct-23-25 10:00AM	Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-22-25 10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-16-25 03:51PM	Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case (Insider Monkey)
Oct-15-25 07:00AM	United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025 (Business Wire)
Oct-13-25 07:00AM	United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting (Business Wire)
Oct-01-25 10:40AM	Is IPF the Next Big Market Opportunity for United Therapeutics? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Sep-30-25 04:38PM	Top Stock Reports for NextEra Energy, U.S. Bancorp and Air Products & Chemicals (Zacks)
Sep-26-25 09:46AM	CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls (The Fly)
11:53AM	Loading…
Sep-19-25 11:53AM	Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? (Zacks)
07:00AM	United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso in Idiopathic Pulmonary Fibrosis (Business Wire)
12:46AM	1 Momentum Stock to Target This Week and 2 We Brush Off (StockStory)
12:03AM	3 Big Reasons to Love United Therapeutics (UTHR) (StockStory)
Sep-16-25 07:00AM	United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum (Business Wire)
Sep-12-25 07:00AM	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress (Business Wire)
Sep-11-25 11:30AM	Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-10-25 02:46PM	United Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last Week (Investor's Business Daily)
Sep-03-25 01:48PM	UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals (Zacks)
09:00AM	Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint (TipRanks)
08:52AM	Pharma, Opendoor, Tesla: Trending Stocks (Yahoo Finance Video)
06:30AM	Lung Disease Breakthrough Boosts United Therapeutics and its Rivals (The Daily Upside)
Sep-02-25 04:09PM	Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It (Investor's Business Daily) +32.83%
09:34AM	Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It (Investor's Business Daily)
07:00AM	United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis (Business Wire)
Aug-29-25 11:30AM	Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report? (Zacks)
07:00AM	United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (Business Wire)
Aug-13-25 12:05AM	5 Insightful Analyst Questions From United Therapeutics's Q2 Earnings Call (StockStory)
Aug-12-25 11:40PM	UTHR Q2 Deep Dive: Tyvaso DPI Drives Growth Amid Pipeline and Competitive Uncertainty (StockStory)
04:06PM	Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United Patent Battle (Investor's Business Daily)
10:00AM	Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt It (Investor's Business Daily)
Aug-11-25 04:15PM	3D Systems Reports Second Quarter 2025 Financial Results (GlobeNewswire)
11:32AM	Merck's Narrowed 2025 Sales View: What it Means After Q2 Results? (Zacks)
Aug-01-25 07:00AM	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program (Business Wire) +7.13%
Jul-31-25 10:15AM	UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y (Zacks)
Jul-30-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks) -5.25%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics (Zacks)
07:35AM	United Therapeutics (UTHR) Misses Q2 Earnings Estimates (Zacks)
06:46AM	United Therapeutics (NASDAQ:UTHR) Misses Q2 Revenue Estimates (StockStory)
06:36AM	United Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results (Business Wire)
Jul-28-25 11:13PM	What To Expect From United Therapeutics's (UTHR) Q2 Earnings (StockStory)
10:00AM	Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline (Zacks)
02:07AM	Leerink Partners Remains a Buy on United Therapeutics Corporation (UTHR) With a $408 PT (Insider Monkey)
Jul-25-25 10:42PM	United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial (Insider Monkey)
Jul-24-25 09:50AM	United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
08:00AM	Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work? (Investor's Business Daily)
Jul-23-25 10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-21-25 06:32PM	United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag (Insider Monkey)
Jul-18-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jul-16-25 07:00AM	United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025 (Business Wire)
Jul-15-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:59AM	Liquidia Receives $50M from HCRx, Accelerates YUTREPIA's Commercial Launch Following Favorable Court Ruling (Insider Monkey)
Jul-11-25 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Jul-10-25 11:26PM	UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) (Insider Monkey)
Jul-09-25 12:33AM	1 Value Stock with Impressive Fundamentals and 2 to Turn Down (StockStory)
Jul-07-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jul-04-25 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-03-25 08:30AM	MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE (Zacks)
Jul-02-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jun-28-25 04:16AM	United Therapeutics Announces World's First Bioengineered External Liver Treatment in Clinical Study (Insider Monkey)
Jun-26-25 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jun-25-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:40AM	5 Must-Read Analyst Questions From United Therapeutics's Q1 Earnings Call (StockStory)
Jun-24-25 12:20PM	MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal (Zacks)
07:00AM	United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver (Business Wire)
Jun-23-25 07:00AM	United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension (Business Wire)
Jun-13-25 02:32AM	United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock? (Zacks)
Jun-11-25 11:04AM	Insmed Stock Jumps 29% on Encouraging PAH Study Results (Zacks)
Jun-10-25 04:07PM	Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia (Investor's Business Daily) -14.32%
02:48PM	Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results (Investopedia)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jun-09-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-06-25 11:31AM	Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-04-25 11:30AM	Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound? (Zacks)
May-30-25 11:31AM	Why Is United Therapeutics (UTHR) Up 9% Since Last Earnings Report? (Zacks)
May-11-25 05:01PM	Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons' Renaissance Technologies? (Insider Monkey)
May-09-25 03:21AM	Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... (GuruFocus.com)
12:01AM	3 Big Reasons to Love United Therapeutics (UTHR) (StockStory)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 04 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 05 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 05 '25	Sale	437.98	4,000	1,751,922	130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 04 '25	Sale	434.13	4,000	1,736,501	130	Nov 06 04:33 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 06 '25	Proposed Sale	448.58	4,000	1,794,308		Nov 06 04:27 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 05 '25	Proposed Sale	437.98	4,000	1,751,922		Nov 05 04:43 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 04 '25	Option Exercise	146.03	21,000	3,066,630	29,118	Nov 05 04:31 PM
EDGEMOND JAMES	CFO AND TREASURER	Nov 04 '25	Sale	436.09	21,000	9,157,821	8,118	Nov 05 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 31 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 03 '25	Option Exercise	120.26	4,000	481,040	4,130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 31 '25	Sale	450.35	4,000	1,801,398	130	Nov 04 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Nov 03 '25	Sale	438.30	4,000	1,753,194	130	Nov 04 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 03 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Nov 04 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Nov 03 '25	Sale	429.25	22,500	9,658,073	0	Nov 04 04:30 PM
JAMES C EDGEMOND	Officer	Nov 04 '25	Proposed Sale	438.66	84,000	36,847,440		Nov 04 04:29 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 04 '25	Proposed Sale	434.13	4,000	1,736,501		Nov 04 04:24 PM
Michael Benkowitz	Officer	Nov 03 '25	Proposed Sale	445.43	90,000	40,088,700		Nov 03 04:23 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Nov 03 '25	Proposed Sale	438.30	4,000	1,753,194		Nov 03 02:48 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 31 '25	Proposed Sale	450.35	4,000	1,801,398		Nov 03 10:12 AM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 29 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 31 05:12 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 30 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 31 05:12 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 30 '25	Sale	448.96	4,000	1,795,837	130	Oct 31 05:12 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 29 '25	Sale	435.78	4,000	1,743,112	130	Oct 31 05:12 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 30 '25	Option Exercise	135.42	11,000	1,489,620	47,781	Oct 30 04:37 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 30 '25	Sale	450.34	11,000	4,953,760	36,781	Oct 30 04:37 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 27 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 30 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 28 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 30 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 27 '25	Sale	415.54	4,000	1,662,173	130	Oct 30 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 28 '25	Sale	415.39	4,000	1,661,555	130	Oct 30 04:30 PM
PAUL MAHON	Officer	Oct 30 '25	Proposed Sale	450.34	11,000	4,953,760		Oct 30 04:05 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 30 '25	Proposed Sale	448.96	4,000	1,795,836		Oct 30 03:24 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 29 '25	Proposed Sale	435.78	4,000	1,743,112		Oct 29 04:24 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 28 '25	Proposed Sale	415.39	4,000	1,661,555		Oct 28 05:02 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 27 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Oct 28 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 27 '25	Sale	417.50	22,500	9,393,671	0	Oct 28 04:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 27 '25	Proposed Sale	415.54	4,000	1,662,173		Oct 27 05:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 23 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 27 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 24 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 27 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 24 '25	Sale	424.06	4,000	1,696,259	130	Oct 27 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 23 '25	Sale	422.18	4,000	1,688,730	130	Oct 27 04:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 24 '25	Proposed Sale	424.06	4,000	1,696,260		Oct 24 03:49 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 23 '25	Proposed Sale	422.18	4,000	1,688,730		Oct 23 04:43 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 21 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 22 05:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 22 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 22 05:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 21 '25	Sale	427.76	4,000	1,711,043	130	Oct 22 05:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 22 '25	Sale	422.15	4,000	1,688,607	130	Oct 22 05:54 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 22 '25	Proposed Sale	422.15	4,000	1,688,607		Oct 22 04:36 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 21 '25	Proposed Sale	427.76	4,000	1,711,043		Oct 21 04:36 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 20 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Oct 21 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 20 '25	Sale	427.41	22,500	9,616,702	0	Oct 21 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 17 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 20 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 17 '25	Sale	430.67	4,000	1,722,687	130	Oct 20 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 20 '25	Sale	424.59	4,000	1,698,350	130	Oct 20 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 20 '25	Proposed Sale	424.59	4,000	1,698,350		Oct 20 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 16 '25	Option Exercise	135.42	11,000	1,489,620	47,781	Oct 20 07:15 AM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 16 '25	Sale	431.50	11,000	4,746,494	36,781	Oct 20 07:15 AM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 17 '25	Proposed Sale	430.67	4,000	1,722,687		Oct 17 03:52 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 16 '25	Proposed Sale	431.31	4,000	1,725,252		Oct 16 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 15 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 16 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 16 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 16 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 15 '25	Sale	435.29	4,000	1,741,164	130	Oct 16 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 16 '25	Sale	431.31	4,000	1,725,253	130	Oct 16 04:30 PM
PAUL MAHON	Officer	Oct 16 '25	Proposed Sale	431.50	11,000	4,746,493		Oct 16 04:02 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 13 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 14 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 13 '25	Sale	440.43	4,000	1,761,730	130	Oct 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 14 '25	Sale	437.47	4,000	1,749,874	130	Oct 15 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 13 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Oct 15 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 13 '25	Sale	440.35	22,500	9,907,963	0	Oct 15 04:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 15 '25	Proposed Sale	435.29	4,000	1,741,164		Oct 15 03:53 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 13 '25	Proposed Sale	440.43	4,000	1,761,732		Oct 14 03:24 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 09 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 10 05:03 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 10 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 10 05:03 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 09 '25	Sale	448.91	4,000	1,795,655	130	Oct 10 05:03 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 10 '25	Sale	444.70	4,000	1,778,788	130	Oct 10 05:03 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 10 '25	Proposed Sale	444.70	4,000	1,778,788		Oct 10 04:56 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 09 '25	Proposed Sale	448.91	4,000	1,795,655		Oct 09 04:50 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 08 '25	Proposed Sale	450.86	4,000	1,803,449		Oct 08 04:53 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 07 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 08 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 08 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 08 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 07 '25	Sale	451.83	4,000	1,807,320	130	Oct 08 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 08 '25	Sale	450.86	4,000	1,803,449	130	Oct 08 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 06 '25	Option Exercise	139.13	22,500	3,130,504	14,625	Oct 07 04:32 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Oct 06 '25	Sale	450.24	22,500	10,130,439	0	Oct 07 04:32 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 07 '25	Proposed Sale	451.83	4,000	1,807,320		Oct 07 04:12 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 03 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 06 05:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 06 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 06 05:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 06 '25	Sale	449.69	4,000	1,798,765	130	Oct 06 05:35 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 03 '25	Sale	446.21	4,000	1,784,847	130	Oct 06 05:35 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 06 '25	Proposed Sale	449.69	4,000	1,798,765		Oct 06 05:25 PM
Michael Benkowitz	Officer	Oct 06 '25	Proposed Sale	453.07	90,000	40,776,300		Oct 06 04:23 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 03 '25	Proposed Sale	446.21	4,000	1,784,847		Oct 03 04:55 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Oct 02 '25	Proposed Sale	434.88	4,000	1,739,525		Oct 02 05:24 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 01 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 02 '25	Option Exercise	120.26	4,000	481,040	4,130	Oct 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 02 '25	Sale	434.88	4,000	1,739,525	130	Oct 02 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Oct 01 '25	Sale	425.45	4,000	1,701,797	130	Oct 02 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 02 '25	Option Exercise	135.42	11,000	1,489,620	47,781	Oct 02 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Oct 02 '25	Sale	436.60	11,000	4,802,574	36,781	Oct 02 04:30 PM

Open in Screener

ARES

Ares Management Corp

Nov 06 • 04:00PM ET

151.26

-1.99 -1.30 %

Financial • Asset Management • USA • NYSE

ARES Ares Management Corp daily Stock Chart

Peers: BX APO KKR CG BAM WELL BXMT MC HLNE KYN

| Held by: VTI VO VUG VXF VOT IWP VYM IWF IWR DGRO

Index	-	P/E	63.14	EPS (ttm)	2.40	Insider Own	5.79%	Shs Outstand	219.43M	Perf Week	2.70%
Market Cap	49.42B	Forward P/E	23.35	EPS next Y	6.48	Insider Trans	-65.12%	Shs Float	206.72M	Perf Month	0.97%
Enterprise Value	65.83B	PEG	2.56	EPS next Q	1.73	Inst Own	88.26%	Short Float	3.34%	Perf Quarter	-19.73%
Income	522.46M	P/S	8.13	EPS this Y	27.46%	Inst Trans	0.33%	Short Ratio	3.80	Perf Half Y	-8.80%
Sales	6.08B	P/B	7.61	EPS next Y	28.04%	ROA	1.72%	Short Interest	6.90M	Perf YTD	-14.56%
Book/sh	19.88	P/C	32.26	EPS next 5Y	24.66%	ROE	13.92%	52W High	200.49 -24.55%	Perf Year	-5.27%
Cash/sh	4.69	P/FCF	21.38	EPS past 3/5Y	-1.20% 14.31%	ROIC	2.94%	52W Low	110.63 36.73%	Perf 3Y	94.57%
Dividend Est.	4.51 (2.98%)	EV/EBITDA	34.35	Sales past 3/5Y	-0.73% 18.68%	Gross Margin	78.15%	Volatility	3.76% 3.61%	Perf 5Y	264.29%
Dividend TTM	4.29 (2.84%)	EV/Sales	10.83	EPS Y/Y TTM	9.49%	Oper. Margin	27.99%	ATR (14)	5.36	Perf 10Y	859.48%
Dividend Ex-Date	Dec 17, 2025	Quick Ratio	0.53	Sales Y/Y TTM	50.70%	Profit Margin	8.60%	RSI (14)	46.82	Recom	1.78
Dividend Gr. 3/5Y	25.54% 23.78%	Current Ratio	0.53	EPS Q/Q	117.47%	SMA20	1.71%	Beta	1.53	Target Price	183.94
Payout	179.61%	Debt/Eq	3.09	Sales Q/Q	70.35%	SMA50	-6.44%	Rel Volume	0.83	Prev Close	153.25
Employees	3200	LT Debt/Eq	3.08	Earnings	Nov 03 BMO	SMA200	-9.32%	Avg Volume	1.82M	Price	151.26
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.34% 1.87%	Trades		Volume	1,501,539	Change	-1.30%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-14-25	Upgrade	Oppenheimer	Perform → Outperform	$180
Oct-03-25	Initiated	BMO Capital Markets	Market Perform	$156
Jul-28-25	Initiated	Raymond James	Mkt Perform
May-15-25	Downgrade	Oppenheimer	Outperform → Perform
Apr-16-25	Upgrade	Oppenheimer	Perform → Outperform	$159
Apr-08-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$165
Jan-27-25	Resumed	Barclays	Overweight	$224
Dec-20-24	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$166 → $202
Dec-12-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-12-24	Initiated	Wells Fargo	Equal Weight	$156
Aug-27-24	Initiated	Redburn Atlantic	Neutral	$140
Jun-13-24	Downgrade	Deutsche Bank	Buy → Hold	$176 → $132
May-28-24	Initiated	Deutsche Bank	Buy	$176
May-07-24	Initiated	TD Cowen	Buy	$154
Jan-09-24	Downgrade	Jefferies	Buy → Hold	$122
Oct-05-23	Initiated	Wolfe Research	Outperform	$133
Jul-10-23	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$99 → $98
Jun-12-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$99 → $93
Nov-14-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$93
Aug-31-22	Initiated	Barclays	Overweight	$92

Show Previous Ratings

Nov-06-25 04:00AM	TalkTalk forced to borrow to pay its bills as losses double (The Telegraph)
Nov-05-25 05:00PM	Ares Management Corporation to Present at the Citizens Financial Services Conference (ACCESSWIRE)
12:05PM	JPMorgans Billionaire Clients Want Sports Teams More Than Fine Art (Bloomberg)
05:32AM	Ares Management Completes Investment in Plenitude (Business Wire)
Nov-04-25 06:43PM	Private-Credit Earnings Ease Investor Concern Over Asset Classs Health (The Wall Street Journal)
04:40PM	Loading…
04:40PM	Private-Credit Earnings Ease Investor Concern Over Market's Health (The Wall Street Journal)
12:32AM	ARES Q3 Deep Dive: Diversified Fundraising and Broad-Based Deployment Drive Earnings Upside (StockStory)
Nov-03-25 01:05PM	Ares Management CEO: 'The wheels are in motion' to bring private investments into 401(k)s (CNBC TV)
06:30AM	Ares Management Announces Third Quarter 2025 U.S. Direct Lending Origination Activity (ACCESSWIRE)
06:19AM	Ares Management: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Ares Management Corporation Reports Third Quarter 2025 Results (Business Wire)
Nov-02-25 07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
Nov-01-25 11:02PM	What To Expect From Ares's (ARES) Q3 Earnings (StockStory)
02:00PM	The Ranks of Corporate Zombies Are Growing: Credit Weekly (Bloomberg)
Oct-31-25 12:05PM	AMP vs. ARES: Which Stock Is the Better Value Option? (Zacks)
09:16AM	Loading…
09:16AM	Ares Management Corp (ARES) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 04:18AM	Ares Management to Acquire BlueCove (Business Wire)
Oct-29-25 11:28AM	Liquid Credits Woes Are Good for Private Lenders, Ares Says (Bloomberg)
09:15AM	Ares Management (ARES) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
06:30AM	Ares Direct Lending Raises $1.5 Billion for Specialty Healthcare Strategy (Business Wire)
Oct-28-25 10:00AM	TPG Inc. (TPG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:00AM	Ares Capital Corporation Announces September 30, 2025 Financial Results and Declares Fourth Quarter 2025 Dividend of $0.48 Per Share (Business Wire)
05:30AM	Private Lenders Aren't Out of the Doghouse Yet (The Wall Street Journal)
04:15AM	Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over 300 Million From Trei Real Estate (Business Wire)
Oct-27-25 10:00AM	Ares Management (ARES) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-24-25 10:35AM	Private-Asset Star Blue Owl Has Been Flying High. Is It Too Close to the Sun? (Barrons.com)
Oct-22-25 01:58PM	GreenBarn Investment Group and Sabal Investment Holdings Lead Refinancing of 817 Broadway in Manhattan (PR Newswire)
Oct-20-25 03:47PM	Credit Fears Make These Alternative Asset Manager Stocks a Buy, Goldman Says (Barrons.com)
06:30AM	Ares Management Appoints Bill Benjamin to Vice Chairman Role (Business Wire)
Oct-17-25 04:50PM	LenderMAC Enters into Strategic Relationship with Ares to Expand Origination and Non-QM Capabilities (PR Newswire)
11:31PM	Loading…
Oct-15-25 11:31PM	Asset Management Stocks Q2 Teardown: Ares (NYSE:ARES) Vs The Rest (StockStory) -6.52%
08:02PM	Banks and Private Credit Clash After Dimons Cockroach Barb (Bloomberg)
03:26PM	The Alt-Manager Selloff Makes Ares Stock a Buy, This Analyst Says (Barrons.com)
09:00AM	Leading Asset Managers Launch Promote Giving, a Groundbreaking Model for Philanthropy Within the Investment Industry (Business Wire)
08:06AM	Ares Management (ARES) Soars 4.1%: Is Further Upside Left in the Stock? (Zacks)
08:01AM	How Promote Giving, a new investment model, will raise millions for charities (Associated Press Finance)
Oct-14-25 01:05PM	Ares (ARES) Stock Is Up, What You Need To Know (StockStory)
10:56AM	Financials Take Center Stage After Bank Earnings. 3 Stocks With Bullish Charts (Barrons.com)
Oct-11-25 02:30AM	Investors Keep Pumping Money into Private Credit, Despite Red Flags (Barrons.com)
Oct-10-25 03:57PM	BDCs Yield 10% or More. They May Be Worth the Risk. (Barrons.com)
Oct-09-25 03:55PM	Ares Management CEO on the value proposition of alternative assets (CNBC TV)
Oct-08-25 10:06AM	Wall Street Pours Billions Into Ares' $5.3B Infrastructure Bet (GuruFocus.com)
06:30AM	Ares Management Raises $5.3 Billion for Infrastructure Secondaries Strategy (Business Wire)
12:01AM	3 Big Reasons to Love Ares (ARES) (StockStory)
Oct-07-25 10:15AM	Ares' deVeer on AI Data Center Boom, Inflation Concerns (Bloomberg)
07:01AM	Ares Management secures 49% ownership in energy portfolio from EDPR (Power Technology)
Oct-06-25 06:29PM	Qualtrics to buy healthcare tech firm Press Ganey in $6.75 billion deal (Reuters)
08:57AM	Qualtrics to buy healthcare tech firm Press Ganey in $6.75 billion deal, FT reports (Reuters)
08:05AM	Ares Management Snags $2.9 Billion Stake In US Renewable Energy Portfolio (Benzinga)
06:30AM	Ares Management Acquires Stake in Diversified U.S. Energy Portfolio from EDPR (Business Wire)
Oct-03-25 06:00AM	Ares Management Corporation Schedules Earnings Release and Conference Call for the Third Quarter Ending September 30, 2025 (ACCESSWIRE)
Oct-01-25 07:05PM	TD Cowen Reaffirms Its Buy Rating on Ares Management Corporation (ARES) with $205 Price Target (Insider Monkey)
Sep-30-25 01:55PM	Ares Management to Buy Minority Stake in EP Wealth (Barrons.com)
09:00AM	Ares Management Buys Minority Stake in $40B EP Wealth (Wealth Management)
07:37AM	After a Trump Order, Private-Markets Managers Blackstone and Ares Get Set to Woo Small Investors (Barrons.com)
Sep-29-25 04:24PM	After a Trump Order, Private-Markets Managers Blackstone and Ares Get Set to Woo Small Investors (Barrons.com)
11:40AM	AMP vs. ARES: Which Stock Should Value Investors Buy Now? (Zacks)
06:30AM	Ares Management Acquires Meade Pipeline to Enhance Energy Infrastructure Portfolio (Business Wire)
03:28AM	Private Credit Gears Up for Biggest Year in Emerging Markets (Bloomberg)
Sep-27-25 02:30AM	A 'Transformational Shift' in Alts Is Underway. What Ares' CEO Sees for Its Future. (Barrons.com)
Sep-26-25 04:49PM	Ares Raises the Stakes With $8 Billion Data Center Bet (GuruFocus.com)
01:20PM	As Robotruck Maker Kodiak Robotics Starts Trading, Should You Buy KDK Stock? (Barchart)
Sep-24-25 04:05PM	Autonomous Truck Startup Kodiak Set to Go Public After $2.5 Billion Deal (The Wall Street Journal) -7.13%
Sep-23-25 10:21AM	Atletico owners negotiating with US firm Apollo over majority stake sale - reports (AFP)
Sep-22-25 09:34PM	Ex-BlackRock Executive Seeks $700 Million for Credit Hedge Fund (Bloomberg)
Sep-19-25 12:11PM	Carlyle Turnaround Halts $1T Merger Talks With Macquarie Group (Zacks)
Sep-09-25 07:01AM	Wall Street Titans Just Dropped $3.9 Billion on This Home Services Empire--Here's Why (GuruFocus.com)
Sep-08-25 11:42AM	Leaf Home Announces Acquisition of Erie Home, Uniting Two Leading Residential Services Providers (PR Newswire)
Sep-06-25 01:13AM	Ares Management Expands in Australia with New Infrastructure Fund (Insider Monkey)
Sep-04-25 04:17PM	Ares CEO Arougheti Sees PE and Sports Investing Colliding (Bloomberg)
Sep-03-25 08:07AM	ID.me tops $2 billion valuation in latest fundraise amid push to combat AI-driven fraud (Reuters)
06:30AM	Ares Management Appoints Anup Agarwal as Head and Chief Investment Officer of Ares Insurance Solutions (Business Wire)
Sep-02-25 05:15PM	Ares Capital Corporation Prices Public Offering of $650 Million 5.100% Unsecured Notes Due 2031 (Business Wire)
06:30AM	Ares Acquisition Corporation II and Kodiak Robotics, Inc. Announce Effectiveness of Registration Statement and September 23, 2025 Extraordinary General Meeting to Approve Business Combination (Business Wire)
Aug-28-25 05:00PM	Ares Management Corporation to Present at the Barclays Global Financial Services Conference (ACCESSWIRE)
Aug-22-25 12:13PM	Private Equity Is Headed for Your 401(k). The Industry Is Celebrating. Should You? (Barrons.com)
Aug-18-25 04:30PM	Ares Management Expands Access to Leading Private Infrastructure Strategy for Australia Wealth Channel (Business Wire)
09:44AM	Analysis-Citi's banking head drives turnaround with more executives, deals, cooperation (Reuters)
09:00AM	Automated Industrial Robotics Inc. Acquires Owens Design (Business Wire)
07:00AM	What Do President Trump's New 401(k) Asset Rules Mean For Your Retirement? (Motley Fool)
Aug-13-25 03:51PM	Citi hires bankers for private credit in North America, tech in Europe (Reuters)
Aug-09-25 01:43PM	Everythings Expensive. Theres Nowhere to Hide: Credit Weekly (Bloomberg)
Aug-08-25 06:17PM	Metas $29 Billion Deal Marks Key Moment for Private Credit (Bloomberg)
12:53PM	FTAI Infrastructure to buy Wheeling & Lake Erie Railway for $1.05bn (Railway Technology)
Aug-07-25 12:53PM	TalkTalk losses hit almost £500m after Dunstone bailout (The Telegraph)
Aug-04-25 10:44AM	Citi names industry veteran as head of North America private credit, memo shows (Reuters)
Aug-02-25 07:49AM	Raymond James Starts Ares Management (ARES) Coverage, Highlights Strong Fee-Based Model (Insider Monkey)
03:15AM	Ares Management Corp (ARES) Q2 2025 Earnings Call Highlights: Record Fundraising and Robust AUM ... (GuruFocus.com)
Aug-01-25 09:30AM	Compared to Estimates, Ares Management (ARES) Q2 Earnings: A Look at Key Metrics (Zacks)
08:27AM	Ares CEO Arougheti on Earnings, M&A Demand, 401(k) Market (Bloomberg)
07:40AM	Ares Management (ARES) Misses Q2 Earnings Estimates (Zacks)
06:37AM	Ares Management: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Ares Management Announces Second Quarter 2025 U.S. Direct Lending Origination Activity (ACCESSWIRE)
06:00AM	Ares Management Corporation Reports Second Quarter 2025 Results (Business Wire)
Jul-31-25 09:18AM	Earnings To Watch: Ares Management Corp (ARES) Reports Q2 2025 Result (GuruFocus.com)
09:00AM	Snowhawk and Nuveen Make Strategic Investment in Prime Data Centers (PR Newswire)
Jul-30-25 06:24PM	Robinhood or AppLovin Could Join S&P 500 if Paramount Is Dumped (Barrons.com)
Jul-29-25 09:15AM	Stay Ahead of the Game With Ares Management (ARES) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:00AM	Ares Capital Corporation Announces June 30, 2025 Financial Results and Declares Third Quarter 2025 Dividend of $0.48 Per Share (Business Wire)
Jul-28-25 04:30PM	Ares Management Establishes Joint Venture With Savion to Invest in U.S. Solar Power Generation (Business Wire)

Ares Management Corp. engages in the provision of investment and consultancy services. It operates through the following segments: Credit Group, Private Equity Group, Real Assets Group, Secondaries Group, and Other. The Credit Group segment includes the management of strategies across the liquid and illiquid spectrum, direct lending, and Asia-Pacific. The Private Equity Group segment involves the categorization of investment strategies as corporate, special opportunities, and Asia-Pacific. The Real Assets Group segment focuses on equity and debt strategies across infrastructure investments. The Secondaries Group segment consists of investment in secondary markets, alternative asset class strategies, private equity, real estate, infrastructure, and credit. The company was founded by Michael J. Arougheti, David B. Kaplan, John H. Kissick, Antony P. Ressler, and Bennett Rosenthal in 1997 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sagati Aghili Naseem	General Counsel	Oct 01 '25	Sale	155.97	21,000	3,275,370	255,397	Oct 03 08:38 PM
NASEEM SAGATI AGHILI	Officer	Oct 01 '25	Proposed Sale	159.89	21,000	3,357,690		Oct 01 04:37 PM
Sagati Aghili Naseem	General Counsel	Sep 10 '25	Sale	178.40	21,000	3,746,321	276,397	Sep 12 07:34 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 10 '25	Sale	178.30	128,837	22,971,970	0	Sep 12 07:33 PM
ARES MANAGEMENT LLC	10% Owner	Sep 10 '25	Sale	1.13	13,000,000	14,710,800	41,197,491	Sep 11 04:31 PM
ARES MANAGEMENT LLC	10% Owner	Sep 09 '25	Sale	1.39	1,631,555	2,261,335	54,197,491	Sep 11 04:31 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 10 '25	Proposed Sale	175.07	128,837	22,555,494		Sep 10 04:40 PM
NASEEM SAGATI AGHILI	Officer	Sep 10 '25	Proposed Sale	175.07	21,000	3,676,470		Sep 10 04:38 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 08 '25	Sale	175.78	170,341	29,942,945	230,237	Sep 09 09:42 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 09 '25	Sale	175.53	101,400	17,799,237	128,837	Sep 09 09:42 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 09 '25	Proposed Sale	176.25	95,701	16,867,301		Sep 09 04:30 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 05 '25	Sale	177.05	176,784	31,300,367	400,578	Sep 05 08:37 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 04 '25	Sale	179.05	161,656	28,945,033	577,362	Sep 05 08:37 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 03 '25	Sale	176.76	126,499	22,359,617	739,018	Sep 05 08:37 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 05 '25	Proposed Sale	180.05	300,000	54,015,000		Sep 05 04:38 PM
TJ CAPITAL INVESTORS LLC	Director	Sep 03 '25	Proposed Sale	179.78	300,000	53,934,000		Sep 03 04:33 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Sep 02 '25	Sale	178.61	177,929	31,780,770	865,517	Sep 02 08:27 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 29 '25	Sale	179.30	101,032	18,115,234	1,043,446	Sep 02 08:27 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 29 '25	Proposed Sale	180.27	300,000	54,081,000		Aug 29 04:17 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 27 '25	Sale	180.23	171,686	30,943,111	1,252,852	Aug 28 08:05 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 28 '25	Sale	180.72	108,374	19,585,265	1,144,478	Aug 28 08:05 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 27 '25	Proposed Sale	178.93	300,000	53,679,000		Aug 27 04:29 PM
Arougheti Michael J	Co-Founder and CEO	Aug 25 '25	Sale	178.19	44,760	7,975,789	0	Aug 26 09:39 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 26 '25	Sale	178.79	196,197	35,077,536	1,424,538	Aug 26 09:38 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 25 '25	Sale	178.08	112,522	20,037,464	1,620,735	Aug 26 09:38 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 26 '25	Proposed Sale	178.13	196,197	34,948,572		Aug 26 04:26 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 25 '25	Proposed Sale	181.07	112,522	20,374,359		Aug 25 04:38 PM
Arougheti Michael J	Co-Founder and CEO	Aug 22 '25	Sale	181.65	105,648	19,191,285	44,760	Aug 22 09:28 PM
Arougheti Michael J	Co-Founder and CEO	Aug 20 '25	Sale	178.39	97,880	17,461,120	213,848	Aug 22 09:28 PM
Arougheti Michael J	Co-Founder and CEO	Aug 21 '25	Sale	178.20	63,440	11,304,739	150,408	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 22 '25	Sale	181.65	105,394	19,144,739	1,733,257	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 20 '25	Sale	178.40	97,971	17,477,619	1,902,029	Aug 22 09:28 PM
RESSLER ANTONY P	Co-Founder & Exec. Chairman	Aug 21 '25	Sale	178.19	63,378	11,293,585	1,838,651	Aug 22 09:28 PM
TJ CAPITAL INVESTORS LLC	Director	Aug 20 '25	Proposed Sale	180.59	300,000	54,177,000		Aug 20 04:21 PM
Arougheti Michael J	Co-Founder and CEO	Aug 19 '25	Sale	182.74	136,516	24,946,638	311,728	Aug 19 08:49 PM
Arougheti Michael J	Co-Founder and CEO	Aug 18 '25	Sale	189.05	85,552	16,173,525	448,244	Aug 19 08:49 PM
Arougheti Michael J	Co-Founder and CEO	Aug 15 '25	Sale	188.69	56,204	10,604,893	533,796	Aug 19 08:49 PM
ATTICUS ENTERPRISES LLC	Director	Aug 18 '25	Proposed Sale	187.78	533,796	100,236,213		Aug 18 04:42 PM
ATTICUS ENTERPRISES LLC	Director	Aug 15 '25	Proposed Sale	190.45	56,204	10,704,052		Aug 15 04:24 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Jun 12 '25	Sale	168.79	85,000	14,347,484	0	Jun 13 07:54 PM
ARES MANAGEMENT LLC	10% Owner	Jun 11 '25	Sale	8.86	2,250,000	19,928,025	117,449,188	Jun 13 04:32 PM
BAR HOLDINGS, LLC	Director	Jun 12 '25	Proposed Sale	168.78	85,000	14,346,300		Jun 12 04:20 PM
KAPLAN DAVID B	Co-Founder	May 30 '25	Sale	165.12	33,145	5,472,902	0	Jun 03 06:37 PM
KAPLAN DAVID B	Co-Founder	May 29 '25	Sale	165.06	23,524	3,882,871	33,145	May 29 08:59 PM
KAPLAN DAVID B	Co-Founder	May 28 '25	Sale	165.06	5,205	859,137	56,669	May 29 08:59 PM
KAPLAN DAVID B	Co-Founder	May 27 '25	Sale	165.07	626	103,334	61,874	May 29 08:59 PM
TRENTLY HOLDINGS, LLC	Officer	May 27 '25	Proposed Sale	160.29	62,500	10,018,125		May 27 04:32 PM
Arougheti Michael J	Co-Founder and CEO	May 20 '25	Sale	166.37	150,000	24,955,537	107,500	May 22 06:41 PM
Arougheti Michael J	Co-Founder and CEO	May 21 '25	Sale	161.34	107,500	17,344,225	0	May 22 06:41 PM
ARES MANAGEMENT LLC	10% Owner	May 16 '25	Sale	8.86	14,960,000	132,499,224	119,699,188	May 20 04:31 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	May 15 '25	Sale	169.37	40,000	6,774,878	85,000	May 19 08:18 PM
KAPLAN DAVID B	Co-Founder	May 15 '25	Sale	169.36	62,500	10,584,827	62,500	May 19 08:18 PM
Arougheti Michael J	Co-Founder and CEO	May 16 '25	Sale	170.07	182,108	30,971,183	350,684	May 19 08:17 PM
Arougheti Michael J	Co-Founder and CEO	May 19 '25	Sale	168.87	93,184	15,735,584	257,500	May 19 08:17 PM
Arougheti Michael J	Co-Founder and CEO	May 15 '25	Sale	169.55	57,208	9,699,584	532,792	May 19 08:17 PM
BAR HOLDINGS, LLC	Officer	May 15 '25	Proposed Sale	175.83	40,000	7,033,200		May 15 04:24 PM
TRENTLY HOLDINGS, LLC	Officer	May 15 '25	Proposed Sale	175.83	62,500	10,989,375		May 15 04:23 PM
ATTICUS ENTERPRISES LLC	Director	May 15 '25	Proposed Sale	175.83	590,000	103,739,700		May 15 04:22 PM
Arougheti Michael J	Co-Founder and CEO	Mar 24 '25	Sale	153.17	110,845	16,977,649	1,400,000	Mar 26 05:58 PM
MICHAEL J AROUGHETI	Officer	Mar 24 '25	Proposed Sale	147.71	110,845	16,372,915		Mar 24 04:22 PM
BHUTANI ASHISH	Director	Mar 11 '25	Buy	141.33	10,000	1,413,300	22,905	Mar 13 08:14 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Mar 04 '25	Sale	161.01	69,809	11,239,742	30,191	Mar 06 09:06 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Mar 05 '25	Sale	160.99	30,191	4,860,362	0	Mar 06 09:06 PM
KAPLAN DAVID B	Co-Founder	Mar 04 '25	Sale	160.99	69,526	11,192,960	30,474	Mar 06 08:57 PM
KAPLAN DAVID B	Co-Founder	Mar 05 '25	Sale	160.99	30,474	4,906,037	0	Mar 06 08:57 PM
TRENTLY HOLDINGS	Officer	Mar 04 '25	Proposed Sale	169.76	100,000	16,976,000		Mar 04 05:10 PM
BAR HOLDINGS, LLC	Officer	Mar 04 '25	Proposed Sale	169.76	100,000	16,976,000		Mar 04 05:10 PM
deVeer R. Kipp	Co-President	Feb 06 '25	Sale	190.02	78,933	14,998,894	1,150,000	Feb 10 08:01 PM
ROBERT KIPP DEVEER	Officer	Feb 06 '25	Proposed Sale	189.65	78,933	14,969,643		Feb 06 04:22 PM
Berry Ryan	Chief Mktg. & Strategy Officer	Dec 11 '24	Sale	180.16	14,357	2,586,557	233,214	Dec 13 08:10 PM
Berry Ryan	Chief Mktg. & Strategy Officer	Nov 27 '24	Sale	180.07	200	36,014	253,014	Dec 13 08:10 PM
ARES MANAGEMENT LLC	10% Owner	Dec 10 '24	Sale	34.37	11,500,000	395,255,000	23,922,768	Dec 12 04:17 PM
Berry Ryan	Chief Mktg. & Strategy Officer	Dec 09 '24	Sale	180.14	5,443	980,502	247,771	Dec 10 09:14 PM
deVeer R. Kipp	Head of Credit Group	Dec 09 '24	Sale	176.82	121,762	21,529,463	1,137,400	Dec 10 09:13 PM
deVeer R. Kipp	Head of Credit Group	Dec 06 '24	Sale	177.83	115,838	20,599,464	1,259,162	Dec 10 09:13 PM
deVeer R. Kipp	Head of Credit Group	Dec 10 '24	Sale	176.57	62,400	11,017,852	1,075,000	Dec 10 09:13 PM
ARES MANAGEMENT LLC	10% Owner	Dec 09 '24	Sale	34.61	300,000	10,384,440	35,422,768	Dec 10 04:32 PM
ARES MANAGEMENT LLC	10% Owner	Dec 06 '24	Sale	34.64	275,000	9,525,092	35,722,768	Dec 10 04:32 PM
ROBERT KIPP DEVEER	Officer	Dec 10 '24	Proposed Sale	175.29	62,400	10,938,096		Dec 10 04:28 PM
ROBERT KIPP DEVEER	Officer	Dec 09 '24	Proposed Sale	178.07	121,762	21,682,159		Dec 09 04:49 PM
ROBERT KIPP DEVEER	Director	Dec 06 '24	Proposed Sale	177.07	115,838	20,511,435		Dec 06 04:35 PM
ARES MANAGEMENT LLC	10% Owner	Dec 03 '24	Sale	34.59	660,000	22,830,258	36,167,768	Dec 05 05:28 PM
ARES MANAGEMENT LLC	10% Owner	Dec 04 '24	Sale	34.52	170,000	5,868,230	35,997,768	Dec 05 05:28 PM
ARES MANAGEMENT LLC	10% Owner	Dec 02 '24	Sale	34.75	475,000	16,505,728	36,827,768	Dec 03 08:06 PM
ARES MANAGEMENT LLC	10% Owner	Nov 29 '24	Sale	34.80	44,940	1,564,114	37,302,768	Dec 03 08:06 PM
Arougheti Michael J	Co-Founder, CEO and President	Nov 27 '24	Sale	176.16	30,465	5,366,612	0	Dec 02 07:22 PM
KAPLAN DAVID B	Co-Founder	Nov 27 '24	Sale	176.16	30,680	5,404,447	0	Dec 02 07:21 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Nov 27 '24	Sale	176.15	29,107	5,127,237	0	Dec 02 07:20 PM
ARES MANAGEMENT LLC	10% Owner	Nov 26 '24	Sale	34.85	106,648	3,716,917	37,431,199	Nov 29 04:50 PM
ARES MANAGEMENT LLC	10% Owner	Nov 27 '24	Sale	34.80	83,491	2,905,812	37,347,708	Nov 29 04:50 PM
BAR HOLDINGS LLC	Officer	Nov 27 '24	Proposed Sale	178.83	29,107	5,205,205		Nov 27 04:39 PM
RYAN BERRY	Officer	Nov 27 '24	Proposed Sale	178.83	20,000	3,576,600		Nov 27 04:37 PM
KAPLAN DAVID B	Co-Founder	Nov 26 '24	Sale	178.17	56,781	10,116,489	30,680	Nov 26 09:19 PM
KAPLAN DAVID B	Co-Founder	Nov 25 '24	Sale	175.82	28,887	5,078,809	87,461	Nov 26 09:19 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Nov 26 '24	Sale	178.17	56,662	10,095,734	29,107	Nov 26 09:14 PM
Rosenthal Bennett	Co-Founder & Chairman of PEG	Nov 25 '24	Sale	175.82	29,198	5,133,703	85,769	Nov 26 09:14 PM
Arougheti Michael J	Co-Founder, CEO and President	Nov 26 '24	Sale	178.17	56,444	10,056,612	30,465	Nov 26 09:09 PM
Arougheti Michael J	Co-Founder, CEO and President	Nov 25 '24	Sale	175.82	29,292	5,150,234	86,909	Nov 26 09:09 PM
ARES MANAGEMENT LLC	10% Owner	Nov 25 '24	Sale	34.88	360,922	12,587,913	37,537,847	Nov 26 04:39 PM
ARES MANAGEMENT LLC	10% Owner	Nov 22 '24	Sale	34.81	227,902	7,934,408	37,898,769	Nov 26 04:39 PM

UTHR

United Therapeutics Corp

ARES

Ares Management Corp

Upgrade your FINVIZ experience